top of page
Leading the Way in Intratumoral Radiotherapeutics
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
JERUSALEM, February 26, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Feb 26, 2024
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the...
Dec 20, 2023
Alpha Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Nov 29, 2023
Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no...
Nov 28, 2023
ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer
Jerusalem, November 20, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative...
Nov 20, 2023
bottom of page